OUTRUN TX

outrun-tx-logo

Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.

#Financial #Website #More

OUTRUN TX

Industry:
Health Care Medical Therapeutics

Address:
Dundee, Dundee City, United Kingdom

Country:
United Kingdom

Website Url:
http://www.outruntx.com

Status:
Active

Email Addresses:
info@outruntx.com

Total Funding:
0


Investors List

mp-healthcare-venture-management-inc_image

MP Healthcare Venture Management

MP Healthcare Venture Management investment in Seed Round - Outrun TX

Official Site Inspections

http://www.outruntx.com

  • Host name: 59.0.153.160.host.secureserver.net
  • IP address: 160.153.0.59
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Outrun TX"

Outrun Therapeutics – Unlocking the therapeutic …

Apr 18, 2024 Our Approach. Outrun Therapeutics is a preclinical biotech using E3 ligase inhibition to unlock the therapeutic potential of protein stabilisation for the treatment of cancer and other diseases.See details»

Our Company – Outrun Therapeutics

Kuan-Chuan (Eric) is a scientist with over 10 years of experience in both chemical and cell biology disciplines. Kuan-Chuan’s experience includes a PhD at MRC-PPU at the University of Dundee, post-doctoral research at UC Berkley and a …See details»

Outrun TX - Crunchbase Company Profile & Funding

Organization. Outrun TX . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Contact Email info@outruntx.com; Outrun TX develops a …See details»

Outrun Therapeutics - LinkedIn

Outrun Therapeutics will be in Cavtat-Dubrovnik, Croatia from the 27 September to 1 October, attending the 'Ubiquitin and ubiquitin-like proteins in health and disease' EMBO workshop. …See details»

Outrun TX Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Outrun TX. Use the PitchBook Platform to explore the full profile.See details»

Outrun Therapeutics launches with a $10m seed financing from M …

Apr 18, 2024 For more information, see: https://outruntx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of science and technology company, Merck. From …See details»

Outrun TX - Products, Competitors, Financials, Employees, …

Outruntx.com. Overview & Products; Financials; People; Founded Year 2019. Stage Seed VC | Alive. Total Raised $10M. Last Raised $10M | 7 mos ago. About Outrun TX. Outrun TX …See details»

Outrun Therapeutics - VentureRadar

Similar Companies: Nurix USA Publicly Traded Nurix, Inc. is a leader in discovering and developing therapies that modulate the ubiquitin proteasome system (UPS). The UPS is a …See details»

Outrun Therapeutics | VentureRadar

Website: https://outruntx.com Develops therapies targeting protein stabilization to combat diseases like cancer and neurodegeneration by inhibiting E3 ligase activity and preventing …See details»

Outrun TX - F6S

Outruntx.com. About Outrun TX. Developer of a technology designed for the identification of therapeutics that selectively target the protein degradation pathway. The company provides a …See details»

Outrun Therapeutics launches with a $10m seed financing from M …

Apr 18, 2024 For more information, see: https://outruntx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of science and technology company, Merck.See details»

Recommended Stories - Yahoo Finance

Apr 18, 2024 Outrun Therapeutics ("Outrun"), the E3 ligase inhibitor and protein stabilisation specialist, today exits from stealth following a $10m seed financing round. Outrun's platform …See details»

Our Platform – Outrun Therapeutics

Our platform – X-E 3 L. Outrun’s X-E 3 L (Crosslinking E3 Labeller) platform is scalable and modular, enabling the generation of E3 ligase inhibitors that stabilise proteins.. Despite the …See details»

Outruntx - Company Profile - Tracxn

Oct 24, 2024 Outruntx - Developer of therapeutics for cancer treatment. Raised a total funding of $10M over 1 round from 2 investors. Outruntx has 21 competitors.See details»

Outrun Therapeutics launches with a $10m seed ... - The Malaysian …

Apr 18, 2024 For more information, see: https://outruntx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of science and technology company, Merck. ...See details»

Outruntx - Raised $10M Funding from 2 investors - Tracxn

Nov 5, 2024 Outruntx raised $10M in its latest funding round, which was Seed round held on Apr 18, 2024. How much funding has Outruntx raised till date? Outruntx has raised a total funding …See details»

My Account

Access and manage your Microsoft account and organizations.See details»

Outlook

Get free Outlook email and calendar, plus Office Online apps like Word, Excel and PowerPoint. Sign in to access your Outlook, Hotmail or Live email account.See details»

Our Approach – Outrun Therapeutics

Restoring health by stabilising proteins. Protein stabilisation seeks to maintain the levels of critical proteins and restore the body’s disease suppression processes, returning proteins to …See details»

Log in to your Okta org

If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, Okta.com, and much more.See details»

linkstock.net © 2022. All rights reserved